Already positive, the research from JP Morgan and its analyst Phil Gresh still consider the stock as a Buy opportunity. The target price has been lifted and is now set at USD 87 compared to USD 83. | February 1, 2022
Analyst Phil Gresh from JP Morgan research considers the stock attractive and recommends it with a Buy rating. The target price is unchanged at USD 76. | June 12, 2021